The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...
Zacks.com on MSN
BAYRY's 2025 Revival: Will the Momentum Continue in 2026?
Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
MedPage Today on MSN
PD-1 inhibitor raises PFS in advanced acral melanoma
First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...
The league clash looked to be heading towards a stalemate at Whitley Park before the young Magpies, targeting back-to-back ...
The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...
The 2024–25 season saw several American players lift trophies in 2025, and the foursome of Ricardo Pepi, Sergiño Dest, Malik ...
It was a busy weekend for a selection of U.S. players in Europe, with goals scored and moves secured. Welcome to the USMNT ...
Bayer Aktiengesellschaft remains deeply undervalued despite ongoing operational and litigation headwinds, supporting a bullish stance. Q3/25 results were weak, but technicals and intrinsic value ...
Chief among the factors driving a sense of optimism among the biopharma leaders was the unfreezing of the biotech investing ...
MedPage Today on MSN
Targeted drug for advanced pancreatic cancer sparks early enthusiasm
The early results showed that 15 of 41 evaluable patients had objective responses and 32 had stable disease with the ...
As we celebrate the festive season, what better gift than a rerank of the best, most in-form teams across Europe's top five leagues?
Utrecht v PSV – 6:15a on ESPN Select: The espresso match of the weekend sees Sergino Dest, Ricardo Pepi and PSV travelling to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results